Efficacy
Testogel® restores testosterone to within the normal range. Normal testosterone levels were achieved at day 182 in 82.2% (139/169) of hypogonadal men treated with an optimised dose, in a randomised placebo-controlled trial involving 274 patients.1
Physical
Kaufman et al evaluated the efficacy of titrated doses of Testogel® in 274 testosterone deficient men* who applied the gel daily for 182 days.1
Efficacy
- Following titration, significantly more subjects receiving active treatment (range 81.6% to 82.5%) had testosterone values within the eugonadal range compared with placebo (range 28.6% to 37.0%) on all study days (p< 0.0001)
Safety
- A similar percentage of serious treatment-emergent adverse events (TEAEs) occurred in the Testogel® (2.1%) and placebo groups (2.5%)
*Inclusion criteria: 18 to 80 years of age; Morning total testosterone < 10.4 nmol/L; Body Mass Index: 18 kg/m2 to 40 kg/m2